Abstract

Abstract Tumor-associated macrophages play a major role in promoting tumor growth and metastasis and in suppressing the anti-tumor immune response. Despite the immunosuppressive environment created by the tumor and enforced by tumor-associated macrophages, treatment of tumor-bearing mice with IL-12 induces tumor regression associated with appearance of activated NK cells and activated tumor-specific cytotoxic T cells. We therefore tested the hypothesis that IL-12 treatment could alter the function of these tumor-associated “suppressor” macrophages. Analysis of tumor infiltrating macrophages (TIMs) and distal tumor associated macrophages (TAMs) revealed that IL-12, both in vivo and in vitro, induced a rapid (< 90 min) reduction of tumor supportive macrophage activities (IL-10, MCP-1, MIF, TGFâ production) and a concomitant increase in pro-inflammatory and pro-immunogenic activities (TNFá, IL-15, IL-18 production). Similar shifts in functional phenotype were induced by IL-12 in TIMs isolated from the primary tumor mass and in TAMs isolated from lung containing metastases, spleen and peritoneal cavity. Therefore, although tumor associated macrophages display a strongly polarized immunosuppressive functional profile, they retain the ability to change their functional profile to pro-inflammatory activities given the appropriate stimulus. The ability of IL-12 to initiate this functional conversion may contribute to early amplification of the subsequent destructive anti-tumor immune response. This research was supported by the Nat’l Cancer Institute, the KY Lung Cancer Research Fdn, the American Lung Assoc., and the KY Research Challenge Trust Fund.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call